Superworth

Surgery Partners price to free cash flow SGRY

Market value divided by free cash flow over the last twelve months, since 2016.

Today, Nov 2, 2026
16.1×
10-year median
13.4×
Against its 10-year history
58th
percentile: 0 is its lowest day, 100 its highest
10-year range
3.4× to 249×
Peer median
18.1×

Surgery Partners' price to free cash flow is 16.1× as of Nov 2, 2026.

That is above its ten-year median of 13.4×, close to the middle of its last ten years.

Over that time it ranged from 3.4× in Aug 2019 to 249× in Dec 2021.

The median for 10 hospital and care facility stocks of a similar size is 18.1×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far16.1×7.6×16.2×
202510.6×10.2×20.1×
202416.3×14.7×29.5×
202327.6×22.6×85.2×
202225.2×23.1×242×
2021249×7.2×249×
20206.9×3.7×12.3×
20198.9×3.4×9.2×
201810.6×8.4×11.7×
20178.0×5.3×14.8×
201610.5×8.9×11.6×

Against its peers

Companies in Medical - Care Facilities nearest Surgery Partners' size, closest first, today.

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Surgery Partners

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.